Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices
- 45 Downloads
To determine the availability of nonprescription needles and syringes (NS) through pharmacy sales and to assess the impact of pharmacy policies and municipal paraphernalia laws on pharmacists' selling practices.
Telephone survey of all pharmacies in Alaska's four largest cities.
Anchorage, Fairbanks, Juneau, and Ketchikan, Alaska.
A single pharmacist from each pharmacy represented in the cities' phone books.
Main Outcome Measures
Reports of (1) pharmacies' policies and individual pharmacists' procedures regarding the nonprescription sale of NS, (2) pharmacists' selling practices, and (3) identification of conditions that may affect pharmacists' decisions to sell nonprescription NS.
Response rate of 86% (37/43); 77% of pharmacists reported selling at least one nonprescription NS in the last month. Store policy was related to selling practices; however, there was no difference in selling practices between a city with a paraphernalia law and cities without such laws. Logistic regression revealed pharmacists were more likely to sell NS if they worked in chain pharmacies and estimated that a high number of other local pharmacists sell nonprescription NS.
NS are available through nonprescription sales in Alaskan pharmacies. The majority of pharmacies have store policies that permit pharmacists to sell nonprescription NS, either in all cases or at their discretion. Municipal paraphernalia laws do not determine the selling practices of individual pharmacists.
KeywordsPublic Health Logistic Regression Large City Telephone Survey Main Outcome Measure
Unable to display preview. Download preview PDF.
- 2.Koester S. Following the blood: syringe reuse leads to blood-borne virus transmission among injection drug users [letter].J Acquir Immune Defic Syndr Hum Retrovirol 1998 July;18(suppl 1):139.Google Scholar
- 3.National Research Council and Institute of Medicine.Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Normand J, Vlahov D, Moses LE, editors. Washington, DC: National Academy Press; 1995.Google Scholar
- 5.Gleghorn AA, Gee G, Vlahov D. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.J Acquir Immune Defic Syndr Hum Retrovirol. 1998 July;18(suppl 1):89–93.Google Scholar
- 9.Case P, Beckett GA, Jones TS. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.J Acquir Immune Defic Syndr Hum Retrovirol 1998 July;18(suppl 1):94–101.Google Scholar
- 11.Wright-De Aguero L, Weinstein B, Jones TS, Miles J. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.J Acquir Immune Defic Syndr Hum Retrovirol 1998 July;18(suppl 1):102–110.Google Scholar
- 12.Lurie P, Wolfe SM. Letter to Harold Varmus.Public Citizen Health Res Group. 1996:2–5.Google Scholar
- 13.Fenaughty AM, Cagle HH, Fisher DG, Reynolds GL. Alaskan drug users' use of pharmacies for purchasing needles. Paper presented at:APHA 126th Annual Meeting and Exhibition. November 15–18, 1998. Washington, DC.Google Scholar
- 14.Cagle HH, Fisher DG, Queen PJ, Des Jarlais DC. Patterns of needle procurement in Anchorage, Alaska. Paper presented at:10 th International Conference on AIDS. August 7–12, 1996. Yokohama, Japan.Google Scholar